Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery
Status:
Completed
Trial end date:
2010-03-09
Target enrollment:
Participant gender:
Summary
This study is conducted in Japan. The aim of this non-interventional study is to investigate
the safety and effectiveness of treatment with eptacog alpha (NovoSeven®) when undergoing
surgery under normal clinical practice conditions.